Mantle Cell Lymphoma (MCL) Current Treatment Practices Meeting 2015

Prof Georg Hess (University Medical Center Mainz, Mainz, Germany) chairs an expert discussion at the Mantle Cell Lymphoma (MCL) Current Treatment Practices Meeting in Brussels, Belgium, for ecancerTV. He is joined by Prof Christian Buske (University of Ulm, Ulm, Germany), Prof Steven Le Gouill (University Hospital of Nantes, Nantes, France) and Prof Eva Kimby (Karolinska Institute, Stockholm, Sweden). In the second part of the discussion the panel members talk about the use of minimal residual disease (MRD) diagnostics and how they may help with the diagnosis of indolent lymphomas and perhaps the earlier treatment of patients.

Prof Georg Hess (University Medical Center Mainz, Mainz, Germany) chairs an expert discussion at the Mantle Cell Lymphoma (MCL) Current Treatment Practices Meeting in Brussels, Belgium, for ecancerTV. He is joined by Prof Christian Buske (University of Ulm, Ulm, Germany), Prof Steven Le Gouill (University Hospital of Nantes, Nantes, France) and Prof Eva Kimby (Karolinska Institute, Stockholm, Sweden). In the second part of the discussion the panel members talk about the use of minimal residual disease (MRD) diagnostics and how they may help with the diagnosis of indolent lymphomas and perhaps the earlier treatment of patients.